James McAdam, the head of Government Affairs and Policy at Bristol Myers Squibb, spoke to BioPharmaDispatch about the opportunity for Australia to build its existing strengths in medical research and its attractiveness as a destination for clinical trials by ensuring national harmonisation of key processes across different jurisdictions and sites.
